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 2 
Summary 1 
Background 2 
Infection is a frequent cause of post-operative morbidity and mortality. The incidence, risk 3 
factors, and outcomes for post-operative infections remain poorly characterised. 4 
 5 
Methods 6 
This is a secondary analyses of a prospective international cohort study of patients aged ≥45 7 
years who had non-cardiac surgery (VISION) including data describing infection within 30 days 8 
after surgery. The primary outcome was post-operative infection. The secondary outcome 9 
was 30-day mortality. We used univariable and multivariable logistic regression to identify 10 
baseline risk factors for infection. Results are presented as n (%) or odds ratio (OR) with 95% 11 
confidence intervals (CI). Some denominators vary according to rates of missing data. 12 
 13 
Results 14 
Among 39,996 surgical patients, 3,905 (9.8%) experienced 5,152 post-operative infections 15 
and 715 (1.8%) died. The most frequent infection was surgical site infection (1,555/3,905 16 
[39.8%]). Infection was most strongly associated with general surgery (OR 3.74 [3.11-4.49]; 17 
p<0.01) and open surgical technique (OR 2.03 [1.82-2.27]; p<0.01). 30-day mortality was 18 
greater amongst patients who experienced infection (262/3,905 [6.7%] vs 453/36,091 19 
patients who did not [1.3%]; OR 3.47 [2.84-4.22]; p<0.01). Mortality was highest amongst 20 
patients with central nervous system infections (OR 14.72 [4.41-49.12]; p<0.01).  21 
 22 
Conclusions 23 
Infection is a common and important complication of non-cardiac surgery, which is associated 24 
with high mortality. Further research is needed to identify more effective measures to 25 
prevent infections after surgery.   26 
 3 
Introduction 1 
There are more than 310 million surgical procedures worldwide each year.1 In the UK, one in 2 
ten adults has a surgical procedure each year, and the annual number of procedures is 3 
increasing steadily.2 Estimates of post-operative morbidity and mortality vary, but 4 
approximately seven million patients worldwide experience a post-operative complication 5 
each year.3-5 Post-operative infections increase morbidity and mortality, and prolong 6 
intensive care and hospital stays.6, 7 7 
 8 
Post-operative infections are a common cause of post-operative death, although estimates 9 
of incidence vary widely. For example, organ space infection has reported mortality rates 10 
between 4 and 9%, and mortality ranges from 28 to 46% in those patients who develop septic 11 
shock.8, 9 However, many post-operative infections do not cause severe sepsis or septic shock 12 
and the mode of death for such patients is unclear in many cases. The literature remains 13 
unclear about the overall rates of post-operative infection and subsequent outcomes.10 14 
Despite many studies focused on specific types of surgery, the relationships between 15 
different types of infection, surgical procedures, and other adverse outcomes are still not 16 
clearly defined.11-13 Source control and antimicrobial therapy are the mainstays of treatment 17 
for post-operative infection. However widespread use of broad-spectrum agents has led to 18 
increasing concerns about antimicrobial resistance, which in itself carries a significant 19 
socioeconomic burden and a high mortality.14, 15 20 
 21 
There are few large epidemiological studies that explore potential risk factors for and 22 
outcomes of post-operative infection. We therefore report a prospective analysis of data 23 
collected during the multi-national, prospective cohort study called the Vascular Events in 24 
Non-cardiac Surgery Patients Cohort Evaluation (VISION) study to evaluate risk factors for 25 
post-operative infection, the incidence of different types of infection, and subsequent 26 
morbidity and mortality.  27 
 4 
Methods 1 
Study cohort 2 
This is a prospective analysis of data collected during the VISION study. The methods of this 3 
prospective international observational cohort study have been described in detail 4 
elsewhere.16 The study was approved by institutional review boards or ethics committees at 5 
each site and was registered with ClincalTrials.gov (NCT00512109). Participants were aged 45 6 
years or older and underwent non-cardiac surgery using general and/or regional anaesthesia, 7 
with at least an expected overnight hospital stay. Participants were approached for written 8 
informed consent before surgery. When this was not possible (e.g. before emergency 9 
surgery), written consent was sought within 24 hours after surgery. In eight sites, where 10 
patients had no next of kin and were unable to provide consent before surgery (e.g., trauma 11 
surgery cases), a deferred consent process was used. 12 
 13 
Data collection 14 
The dataset for these analyses includes all patients with outcome data restricted to 30 days 15 
after surgery. Detailed and standardised data were collected before surgery, during hospital 16 
stay until discharge and then at 30 days after surgery. Where an infection occurred, additional 17 
data were collected. Full definitions of the variables included in this analysis are documented 18 
in supplementary information. 19 
 20 
Outcome measures 21 
The primary outcome measure was infection within 30 days after surgery. Diagnosis of 22 
infection was made by clinical evidence meeting CDC/NHSN Surveillance definitions for 23 
specific types of infections.17 Infection outcomes were graded by severity using Clavien-Dindo 24 
classification (supplementary file).18, 19 The secondary outcome measure was 30-day 25 
mortality. As an exploratory objective, we also evaluated the association between post-26 
operative infection and Myocardial Injury After Noncardiac Surgery (MINS) (supplementary 27 
file). To determine whether the presence of post-operative infection influenced the delivery 28 
of care, we used the following tertiary process measures: hospital length of stay and 29 
admission to intensive care. 30 
 31 
 5 
Statistical analysis 1 
A prospective statistical analysis plan was completed before commencing any analyses. All 2 
analyses were performed using Stata 15.1 (StataCorp, USA). Cases that were missing outcome 3 
data were excluded by list-wise deletion. We present descriptive statistics for baseline 4 
characteristics for patients with and without post-operative infection as well as different 5 
types of infection. For patients who had more than one incidence of infection, we included 6 
only the event with the highest Clavien-Dindo severity grading to prevent duplication of 7 
patients included in analyses. A number of patients had more than one category selected for 8 
type of surgery. We excluded these in the main analyses in order to evaluate impact of each 9 
type on infection risk. We then evaluated the impact of having more than one type of surgery 10 
separately. Categorical data are reported n (%). Normally distributed data are expressed as 11 
mean and standard deviation (SD), non-normally distributed data are expressed as median 12 
and interquartile range (IQR). 13 
 14 
We used univariable and multivariable logistic regression analysis to test for association 15 
between post-operative infection within 30 days after surgery and known risk factors for 16 
perioperative morbidity and mortality. Post-operative infection was the dependent variable 17 
and the following risk factors were included as independent variables: age (<65, 65-85, ≥85 18 
years), male sex, smoking status (never, ex-smoker, current smoker), body mass index (BMI) 19 
(<18.5, 18.5-24.9, ≥25, ≥30), co-morbidities (current atrial fibrillation, previous atrial 20 
fibrillation, congestive heart failure, coronary artery disease, cerebral vascular event, 21 
peripheral vascular disease, hypertension, chronic obstructive pulmonary disease, diabetes, 22 
active cancer), pre-operative haemoglobin level, pre-operative estimated glomerular 23 
filtration rate (eGFR) (<30, 30-44, 45-60, >60 ml min-1), urgency of surgery (<72 hours, all 24 
other), type of surgery (vascular, general, thoracic, major urology or gynaecology, major 25 
orthopaedic, major neurosurgery, low risk surgery), surgical technique (endoscopic only, 26 
open), type of anaesthetic (general, regional, combined). Results of logistic regression 27 
analyses are presented as odds ratios (OR) with 95% confidence intervals (CI). 28 
 29 
Secondary and tertiary analyses 30 
To determine whether post-operative infection was associated with the secondary outcome 31 
measure defined as 30-day mortality, we conducted univariable and multivariable logistic 32 
 6 
regression analysis. We used post-operative infection within 30 days after surgery as the 1 
independent variable and 30-day mortality as the dependent variable. Models were corrected 2 
for previously identified covariates in the primary analysis. The outcome variables were 3 
categorised by presence of infection, type of infection, and severity of infection. Forest plots 4 
for risk of 30-day mortality show the impact of each infection type using univariable analyses.  5 
 6 
We performed time-to-event analysis and provide Kaplan-Meier plots for the relationship 7 
between post-operative infection and mortality. To determine whether the presence of post-8 
operative infection influenced delivery of care we used hospital length of stay as a tertiary 9 
process measure. We constructed univariable linear and logistic regression models with post-10 
operative infection within 30 days after surgery as the independent variable and either 11 
hospital length of stay as the dependent variable. The results were presented as beta 12 
coefficients with 95% CI for the linear regression model.13 
 7 
Results 1 
A total of 40,037 patients were recruited to the VISION study between August 6th 2007 and 2 
January 11th 2011, of whom 40,004 had baseline data available for inclusion into this study.  3 
We excluded 8 patients with missing outcome data for post-operative infection leaving 4 
39,996 for inclusion in the primary analyses (supplementary figure 1: STROBE flow diagram). 5 
Post-operative infection within 30 days following surgery occurred in 3,905 (9.8%) patients. 6 
Baseline characteristics for all patients and patients categorised by presence of post-7 
operative infection are presented in Table 1. The majority of patients in our cohort underwent 8 
low risk surgery (38.3%), general surgery (19.9%), and orthopaedic surgery (17.5%). The age 9 
of patients who developed post-operative infection was higher than those who did not. A 10 
higher proportion of patients with infection were current smokers or ex-smokers, had a co-11 
morbidity, lower pre-operative haemoglobin, and lower pre-operative eGFR. Patients who 12 
developed infection were more likely to have undergone urgent surgery and open surgical 13 
technique. 14 
 15 
Baseline characteristics for patients categorised by type of infection are presented in Table 2. 16 
A number of patients developed more than one infection. There was a total of 5,152 infection 17 
events among 3,905 patients. Surgical site infection (n=1555), urinary tract infection 18 
(n=1086), and pneumonia (n=771) were the most common types of infection. More than one 19 
in five patients who had an infection (n=843, 21.6%) experienced more than one infection 20 
during their hospital stay; 590 patients had two, 164 patients had three, 49 patients had four, 21 
30 patients had five, and ten patients had more than five infections. Incidences listed as 22 
‘other’ included infection types that did not fall under the other categories such as 23 
gastroenteritis, methicillin-resistant staphylococcus aureus (MRSA), and iatrogenic line 24 
infections. A greater proportion of patients who developed upper respiratory tract infection 25 
had a current or ex-smoker history (73.0%) compared to other types of infection ranging from 26 
13.3% (central nervous system) to 62.1% (peritonitis). 27 
 28 
In patients who developed infection, 35.8% had undergone a general surgical procedure. 29 
General surgery was the surgical category with the highest rate of infection (1400/7950 30 
[17.6%]).  Patients who did not develop post-operative infection most commonly underwent 31 
 8 
low risk surgery (35.9%). A number of patients had surgery that came under more than one 1 
category, 1,099 patients had two (2.7%), 66 patients had three (0.2%). These patients were 2 
excluded from our main analyses in order to test the effect different types of surgery had on 3 
development of infection. We then replaced the type of surgery variable with numbers of 4 
surgery performed and showed that having more than one category of surgery carried higher 5 
risk of post-operative infection compared to having only one category (supplementary table 6 
1). Distribution of different types of infection varied between different types of surgery. The 7 
majority of patients who developed infection after general surgery had incision site (41.1%) 8 
and urinary tract (22.0%) infections. 9 
 10 
The results of multivariable logistic regression analyses for predetermined baseline 11 
characteristics against development of post-operative infection are listed in Table 3. 12 
Development of post-operative infection was associated with increasing age (≥85 years OR 13 
1.80 [1.51-2.15]; p<0.01), 65-85 years OR 1.23 [1.13-1.33]; p<0.01, both compared to <65 14 
years), male sex (OR 1.12 [1.04-1.22]; p<0.01), smoking history (current smoker: OR 1.37 15 
[1.22-1.54]; p<0.01; ex-smoker: OR 1.29 [1.18-1.40]; p<0.01). In this cohort, patients with a 16 
higher pre-operative haemoglobin levels had lower rates of post-operative infection (OR 0.90 17 
[0.88-0.91] per gram unit rise; p<0.01). Patients at the extremes of BMI range had higher rates 18 
of post-operative infection compared to those within normal range (BMI 18.5-24.9): 19 
underweight (BMI <18.5) (OR 1.33 [1.11-1.60], p<0.01) and obese (≥30) (OR 1.11 [1.01-1.23]; 20 
p=0.03). Rates of infection was higher in patients with lower pre-operative eGFR <30 ml min-21 
1 (OR 1.38 [1.17-1.63]; p<0.01) or 30-44 ml min-1 (OR 1.23 [1.05-1.44]; p=0.01) compared to 22 
>60 ml min-1. 23 
 24 
Rates of post-operative infection were higher in patients who had urgent surgery within 72 25 
hours of acute event defined as an acute illness admission (OR 1.41 [1.26-1.58]; p<0.01), and 26 
an open surgical technique (OR 2.03 [1.82-2.27]; p<0.01). Compared to using general 27 
anaesthesia, regional anaesthesia was associated with lower post-operative infection rates 28 
both used alone (OR 0.78 [0.69-0.87]; p<0.01), or in a combined regional and general 29 
anaesthesia approach (OR 0.78 [0.65-0.95]; p=0.01).  30 
 9 
Secondary analyses 1 
Patients who developed post-operative infection had a higher 30-day mortality rate (OR 3.47 2 
[2.82-4.22]; p<0.01). When categorised by infection type, statistically significant associations 3 
were observed for all types apart from surgical abscess, urinary tract infection, upper 4 
respiratory tract infection, and osteomyelitis. The highest mortality risks were with CNS 5 
infections (OR 14.72 [4.41-49.12]; p<0.01), and positive blood culture without a clear primary 6 
source (OR 9.06 [5.08-16.17]; p<0.01). Severe infection within Clavien-Dindo grading III and 7 
above was associated with higher mortality (OR 13.55 [10.80-17.01]; p<0.01). In the adjusted 8 
analyses, less severe infection within Clavien-Dindo grading I to II had lower mortality rates 9 
compared to no infection (OR 0.51 [0.33-0.79]; p<0.01) (Table 4). Presence of post-operative 10 
infection was associated with longer hospital length of stay (12.75 days [12.39-13.12]; 11 
p<0.01). 12 
13 
 10 
Discussion 1 
The principal finding of this analysis is that one in ten patients developed an infection within 2 
30 days of surgery, and one in five of these patients developed multiple infections. 30-day 3 
mortality rates were more than three times greater for surgical patients who experienced an 4 
infection. Surgical site infection, urinary tract infection and pneumonia were the most 5 
frequent events. Infection was most common among patients recovering from general 6 
surgery and those who had general anaesthesia. This could be related to the risk profile of 7 
surgery or could be causative from increased infective risks following general anaesthesia 8 
including procedures such as urinary catheterisation. The frequency with which different 9 
types of infection occur varied between different surgical specialities. Having multiple surgical 10 
categories also increased risk of post-operative infection. Multi-specialty involvement may 11 
imply a higher degree of surgical complexity, and therefore a higher risk of post-operative 12 
complications. 13 
 14 
The strongest risk factors for infection were older age, smoking history, and co-morbid 15 
disease. This is important because the number of elderly patients undergoing surgery 16 
continues to rise, with one in five people in England aged ³75 years undergoing surgery in 17 
2015.20 Patients who were either underweight or obese experienced more infections, as did 18 
patients with anaemia and impaired renal function. There have been a number of previously 19 
published studies measuring post-operative infection rates and outcomes. Most of them are 20 
within single surgical specialities or even specific procedures and focusing on reporting one 21 
type of infection only. Mostly commonly, these have been surgical site infection, urinary tract 22 
infections, and pneumonia because these infections are most frequent, with orthopaedic 23 
surgery being most often evaluated.21, 22 The most extensively reported has been surgical site 24 
infection with rates ranging from 3% (multiple surgical categories combined, costs-analysis 25 
study) to 36% (otolaryngology, cohort study).23, 24 26 
 27 
Our findings are consistent with identifying previously reported risk factors. Various 28 
pathophysiological consequences of smoking have been proposed to explain the increased 29 
development of infection, particularly surgical site infection. These include impaired early 30 
host cellular defences reducing the ability to control bacterial wound contamination and 31 
 11 
prolonged tissue acidosis.25 For orthopaedic surgery joint replacement, evidence to support 1 
pre-operative modification of risk factors is strongest for diabetes and smoking.26 2 
Malnutrition has been thought to impair wound healing and prolong inflammation via 3 
mechanisms such as impaired fibroblast proliferation and collagen synthesis.27 Patients 4 
undergoing primary hip and knee arthroplasty have previously had improved perioperative 5 
outcomes following neuraxial versus general anaesthesia including reduced infections.28 6 
Similarly, general anaesthesia for caesarean sections were also associated with a higher 7 
incidence of surgical site infection compared with neuraxial anaesthesia.29 Furthermore, our 8 
findings support that from a meta-analysis of joint arthroplasty procedures showing lower 9 
rates of surgical site infection following neuraxial anaesthesia.30 Conversely, the effects of co-10 
morbidities such as coronary artery disease, hypertension, and diabetes have not been 11 
replicated following our adjusted analyses.31, 32 This may reflect the fact the underlying 12 
mechanisms behind these co-morbidities may interact and therefore not demonstrate an 13 
effect due to loss of statistical power. The finding of less severe infection within Clavien-Dindo 14 
grading I to II on adjusted analyses having lower mortality rates compared to no infection is a 15 
likely artefact due to the low risk nature of patient groups which have Clavien-Dindo I and II 16 
infection compared to the high-risk nature of those who develop grade III and above infection. 17 
These patient groups are likely to have more co-morbidities and confounding risk factors not 18 
taken into account in unadjusted analyses. 19 
 20 
Development of post-operative infection was associated with mortality, particularly when 21 
patients developed CNS infections or peritonitis. This supports multiple studies which have 22 
previously reported associations between post-operative infection and mortality across 23 
surgical specialities.33 The increased risk seen from our results are consistent with a previous 24 
study reporting that three-year mortality following radical cystectomy is 10.2% amongst 25 
patients developing surgical site infection compared to only 4.2% in non-infected patients.34  26 
 27 
The strengths of our analyses are that we evaluated risk factors and patterns of development 28 
of various post-operative infection across a range of surgical specialities within a single large 29 
cohort. Our multi-centre study design and the large varied population make our results 30 
broadly generalisable to patients having non-cardiac surgery. The statistical analyses were 31 
pre-specified and multivariable models used to correct for confounding factors. However, the 32 
 12 
limitation of our study is the observational design. Many important factors were prospectively 1 
recorded, but there will be a degree of unmeasured confounding for example between 2 
cardiovascular risk factors and it is difficult to estimate how residual confounding may have 3 
altered our conclusions. We excluded patients with multiple infection events and patients 4 
categorised into more than one type of surgery when analysing the effect of each variable. 5 
Looking specifically between different types of infections resulted in smaller sample sizes in 6 
some categories, and so we have not assessed whether certain risk factors conferred a greater 7 
risk of various types of post-operative infection within surgical specialties. The true 8 
associations with individual risk factors remain unclear due to likely interactions between risk 9 
factors both from residual confounding and potential effect modification. For example, 10 
smoking history and co-morbidities including coronary artery disease and peripheral vascular 11 
disease, diabetes, or reduced renal function defined by lower eGFR and pre-operative 12 
anaemia defined by lower haemoglobin levels. Limitations of the dataset include incomplete 13 
data and lack of variables such as aggregated scoring systems to measure the burden of co-14 
morbidities, frailty, socioeconomic status, elective versus emergency surgery. Surgical 15 
categories were also not able to be categorised by level of contamination. 16 
 17 
Conclusions 18 
We have described post-operative infection rates in a large international cohort of patients 19 
undergoing non-cardiac surgery. This has allowed us to provide accurate and generalisable 20 
estimates of the key risk factors for infection and subsequent patient outcomes. Infection is 21 
a common and important complication of non-cardiac surgery which is associated with high 22 
mortality. We have also shown an association with MINS but are unable to explore the 23 
underlying cause of this. New treatment approaches are needed to prevent infection which 24 
rely less on antimicrobial drugs and focus on better prevention strategies warranting further 25 
research. The risks of infection should be discussed with patients before surgery.  26 
 13 
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Table 1. Baseline characteristics for all patients, categorised by infection status. All data presented as 1 
n (%) unless otherwise specified, total n for variables with missing data listed as [n], SD – standard deviation, 2 
IQR – interquartile range. BMI – body mass index, Hb – haemoglobin, eGFR – estimated glomerular filtration 3 
rate. Current smoker defined as within 30 days before surgery. 1 8 patients had missing infection outcome. 2 BMI 4 
were calculated using height and weight values, height outside of range 1.40-2.00 m and weight outside of range 5 
40-150 kg were excluded for biological plausibility and to eliminate extreme outliers. 3 Hb values greater than 6 
20.0 g dL-1 were also excluded for biological plausibility and to eliminate extreme outliers. 4 1,165 patients had 7 
surgery which came under more than one category: 1,099 had two, 66 had three. 8 
 All patients n=40004 
No infection 1 
n=36091 
Infection 1 
n=3905 
Age in years 
Mean (SD) 64.0 (11.3) 63.7 (11.2) 66.8 (11.9) 
Median (IQR) 63.2 (54.8-72.5) 62.9 (54.7-72.0) 66.4 (57.4-75.9) 
<65 22141 (55.3) 20350 (56.4) 1786 (45.7) 
65-85 16434 (41.1) 14570 (40.4) 1861 (47.7) 
≥85 1429 (3.6) 1171 (3.2) 258 (6.6) 
Sex 
Male 20127 (50.3) 18075 (50.1) 2047 (52.4) 
Smoking status 
Never smoked 21195 (53.8) 19422 (54.6) 1766 (46.1) 
Ex-smoker 12591 (32.0) 11124 (31.3) 1467 (38.3) 
Current smoker 5615 (14.3) 5015 (14.1) 600 (15.7) 
 [39401] [35561] [3833] 
BMI 2 
Underweight <18.5 1227 (3.3) 1042 (3.1) 185 (5.1) 
Normal range 18.5 – 24.9 13327 (35.4) 12013 (35.3) 1311 (36.3) 
Overweight ≥25 13093 (34.8) 11936 (35.1) 1154 (31.9) 
Obese ≥30 9976 (26.5) 9012 (26.5) 964 (26.7) 
 [37623] [34003] [3614] 
Co-morbidities 
Current atrial fibrillation 1123 (2.8) 914 (2.5) 209 (5.4) 
 [39876] [35980] [3889] 
Previous atrial fibrillation 1262 (3.2) 1058 (2.9) 204 (5.3) 
 [39827] [35943] [3878] 
Congestive heart failure 1424 (3.6) 1182 (3.3) 241 (6.2) 
 [39870] [35973] [3890] 
Coronary artery disease 5159 (12.9) 4512 (12.5) 646 (16.6) 
 [39876] [35979] [3890] 
Cerebral vascular event 2582 (6.5) 2206 (6.1) 375 (9.6) 
Peripheral vascular disease 3203 (8.0) 2748 (7.6) 455 (11.7) 
Hypertension 20152 (50.5) 17933 (49.8) 2217 (56.9) 
 [39917] [36013] [3897] 
Chronic obstructive pulmonary disease 3165 (7.9) 2658 (7.4) 506 (13.0) 
Diabetes 8332 (20.9) 7383 (20.5) 947 (24.3) 
 [39905] [36001] [3897] 
Active cancer 6168 (15.4) 5333 (14.8) 834 (21.4) 
 [40002] [36091] [3903] 
Pre-operative Hb level in g dL-1 3 
Mean (SD) 13.0 (2.0) 13.1 (1.9) 12.5 (2.1) 
Median (IQR) 13.2 (11.9-14.3) 13.2 (12.0-14.4) 12.7 (11.0-14.0) 
 [38614] [34769] [3841] 
Pre-operative eGFR 
<30 1515 (4.1) 1265 (3.8) 250 (6.7) 
30-44 1774 (4.8) 1512 (4.5) 262 (7.0) 
45-60 3707 (9.9) 3262 (9.7) 444 (11.9) 
>60 30294 (81.2) 27499 (82.0) 2792 (74.5) 
 [37290] [33538] [3748] 
Urgency of surgery 
<72 hours since acute event 4189 (10.5) 3585 (9.9) 604 (15.5) 
All other surgeries 35815 (89.5) 32506 (90.1) 3301 (84.5) 
 17 
Type of surgery 4 
Vascular 2642 (6.6) 2354 (6.5) 287 (7.4) 
 [39997] [36085] [3904] 
General 7950 (19.9) 6549 (18.2) 1400 (35.9) 
Thoracic 1165 (2.9) 1074 (3.0) 91 (2.3) 
Major urology or gynaecology 4827 (12.1) 4407 (12.2) 420 (10.8) 
Major orthopaedic 6982 (17.5) 6216 (17.2) 764 (19.6) 
Major neurosurgery 2341 (5.9) 2114 (5.9) 227 (5.8) 
Low risk surgery 15308 (38.3) 14394 (39.9) 910 (23.3) 
Surgical technique 
Endoscopic only 8683 (21.7) 8167 (22.6) 516 (13.2) 
Open 31288 (78.3) 27901 (77.4) 3381 (86.8) 
 [39971] [36066] [3899] 
Type of anaesthetic 
General 27069 (69.3) 24164 (68.6) 2903 (75.4) 
Regional 10005 (25.6) 9218 (26.2) 786 (20.4) 
Combined 1997 (5.1) 1836 (5.2) 161 (4.2) 
 [39071] [35218] [3850] 
1 
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Table 2. Baseline characteristics for patients with infection, categorised by infection type. All data presented as n (%) unless otherwise specified, total n for 
variables with missing data listed as [n], SD – standard deviation, IQR – interquartile range. BMI – body mass index, UTI – urinary tract infection, URTI – upper respiratory 
tract infection, CNS – central nervous system. Current smoker defined as within 30 days before surgery. 1 BMI were calculated using height and weight values, height outside 
of range 1.40-2.00 m and weight outside of range 40-150 kg were excluded for biological plausibility and to eliminate extreme outliers. 2 Hb values greater than 20.0 g dL-1 
were also excluded for biological plausibility and to eliminate extreme outliers. Note a number of patients had incidences of more than one infection: 590 had two, 164 had 
three, 49 had four, 30 had five, three had six, three had seven, three has eight and one had nine. Only the infection event with the highest severity grading was included for 
each patient. 3 1,165 patients had surgery which came under more than one category: 1,099 had two, 66 had three. An extended table including co-morbidities, pre-operative 
haemoglobin level, estimated glomerular filtration rate, surgical technique is included in the supplement. 
 
Surgical 
incision 
n=1555 
Surgical 
abscess 
n=340 
UTI 
n=1086 
URTI 
n=101 
Pneumonia 
n=771 
Peritonitis 
n=134 
Osteomyelitis 
n=29 
CNS 
n=33 
Blood culture 
n=115 
Other 
n=761 
Age in years 
Mean (SD) 64.9 (11.4) 63.7 (10.9) 70.0 (12.4) 68.2 (10.9) 63.9 (11.3) 66.2 (11.7) 63.4 (13.4) 56.9 (9.5) 65.9 (11.9) 66.5 (11.8) 
Median (IQR) 64.5 (55.8-73.6) 63.2 (54.9-72.3) 71.0 (60.9-79.5) 67.8 (61.3-76.4) 63.1 (54.8-72.4) 66.5 (57.4-74.9) 61.2 (51.0-75.6) 56.5 (49.1-60.3) 65.6 (55.7-74.9) 65.9 (57.4-74.7) 
<65 799 (51.4) 196 (57.7) 378 (34.8) 40 (39.6) 310 (40.2) 59 (44.0) 19 (65.5) 27 (81.8) 55 (47.8) 351 (46.1) 
65-85 702 (45.1) 135 (39.7) 583 (53.7) 54 (53.5) 403 (52.3) 69 (51.5) 8 (27.6) 6 (18.2) 53 (46.1) 365 (48.0) 
≥85 54 (3.5) 9 (2.7) 125 (11.5) 7 (6.9) 58 (7.5) 6 (4.5) 2 (6.9) 0 (0) 7 (6.1) 45 (5.9) 
Sex 
Male 836 (53.8) 188 (55.3) 422 (38.9) 70 (69.3) 474 (61.5) 87 (64.9) 22 (75.9) 14 (42.4) 69 (60.0) 435 (57.2) 
Smoking status 
Never smoked 703 (46.0) 155 (46.0) 547 (51.1) 26 (27.1) 307 (41.0) 50 (37.9) 14 (50.0) 26 (86.7) 55 (49.6) 315 (42.3) 
Ex-smoker 573 (37.5) 97 (38.3) 408 (38.1) 47 (49.0) 302 (40.4) 56 (42.4) 10 (35.7) 3 (10.0) 39 (35.1) 303 (40.7) 
Current smoker 254 (16.6) 53 (15.7) 115 (10.8) 23 (24.0) 139 (18.6) 26 (19.7) 4 (14.3) 1 (3.3) 17 (15.3) 126 (16.9) 
 [1530] [337] [1070] [96] [748] [132] [28] [30] [111] [744] 
BMI 1 
Underweight <18.5 65 (4.5) 12 (3.7) 45 (4.5) 2 (2.2) 66 (9.3) 7 (5.6) 0 (0) 0 (0) 3 (2.8) 39 (5.6) 
Normal range 18.5–24.9 478 (33.1) 138 (42.6) 364 (36.2) 34 (37.0) 285 (40.2) 48 (38.1) 8 (32.0) 11 (50.0) 37 (34.3) 248 (35.4) 
Overweight ≥25 445 (30.8) 95 (29.3) 346 (34.4) 30 (32.6) 203 (28.6) 41 (32.5) 9 (36.0) 4 (18.2) 44 (40.7) 228 (32.5) 
Obese ≥30 456 (31.6) 79 (24.4) 250 (24.9) 26 (28.3) 155 (21.9) 30 (23.8) 8 (32.0) 7 (31.8) 24 (22.2) 186 (26.5) 
 [1444] [324] [1005] [92] [709] [126] [25] [22] [108] [701] 
Urgency of surgery 
<72 hours since acute 
event 
203 (13.1) 35 (10.3) 191 (17.6) 9 (8.9) 167 (21.7) 39 (29.1) 4 (13.8) 9 (27.3) 15 (13.0) 115 (15.1) 
All other surgeries 1352 (87.0) 305 (89.7) 895 (82.4) 92 (91.1) 604 (78.3) 95 (70.9) 25 (86.2) 24 (72.7) 100 (87.0) 646 (84.9) 
 [1555] [340] [1086] [101] [771] [134] [29] [33] [115] [761] 
Type of surgery 3 
Vascular 116 (7.5) 9 (2.7) 57 (5.3) 11 (10.9) 65 (8.4) 3 (2.2) 1 (3.5) 1 (3.0) 10 (8.7) 81 (10.6) 
 [1555] [339] [1086] [101] [771] [134] [29] [33] [115] [761] 
General 576 (37.0) 221 (65.0) 308 (28.4) 43 (42.6) 292 (37.9) 111 (82.8)  2 (6.9)  1 (3.0) 41 (35.7) 282 (37.1) 
19 
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 [1555] [340] [1086] [101] [771] [134] [29] [33] [115] [761] 
Thoracic 20 (1.3) 3 (0.9) 13 (1.2) 2 (2.0) 54 (7.0)  1 (0.8)  0 (0)  0 (0) 5 (4.4) 22 (2.9) 
 [1555] [340] [1086] [101] [771] [134] [29] [33] [115] [761] 
Major urology or 
gynaecology 
141 (9.1) 39 (11.5) 200 (18.4) 5 (5.0) 56 (7.3) 5 (3.7)  0 (0)  0 (0) 9 (7.8) 68 (8.9) 
[1555] [340] [1086] [101] [771] [134] [29] [33] [115] [761] 
Major orthopaedic 307 (19.7) 21 (6.2) 278 (25.6) 11 (10.9) 126 (16.3)  0 (0) 11 (37.9) 2 (6.1) 19 (16.5) 134 (17.6) 
 [1555] [340] [1086] [101] [771] [134] [29] [33] [115] [761] 
Major neurosurgery 56 (3.6) 11 (3.2) 81 (7.5) 12 (11.9) 72 (9.3) 1 (0.8) 2 (6.9) 13 (39.4) 8 (7.0) 44 (5.8) 
 [1555] [340] [1086] [101] [771] [134] [29] [33] [115] [761] 
Low risk surgery 415 (26.7) 56 (16.5) 234 (21.6) 19 (18.8) 145 (18.8) 16 (11.9) 13 (44.8) 18 (54.6) 24 (20.9) 154 (20.2) 
 [1555] [340] [1086] [101] [771] [134] [29] [33] [115] [761] 
Type of anaesthetic 
General 1118 (73.2) 291 (86.9) 773 (71.8) 83 (82.2) 630 (82.8) 125 (94.0) 12 (42.9) 33 (100) 97 (84.4) 591 (78.9) 
Regional 343 (22.5) 33 (9.9) 265 (24.6) 15 (14.9) 103 (13.5) 5 (3.8) 13 (46.4) 0 (0) 12 (10.4) 127 (17.0) 
Combined 67 (4.4) 11 (3.3) 38 (3.5) 3 (3.0) 28 (3.7) 3 (2.3) 3 (10.7) 0 (0) 6 (5.2) 31 (4.1) 
 [1528] [335] [1076] [101] [761] [133] [28] [33] [115] [749] 
 
